Ahmet Gulluoglu

Dr. Ahmet Gulluoglu


Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 September 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
AGAhmet Gulluoglu
Ahmet Gulluoglu
ADALPARSLAN DENİZ
ALPARSLAN DENİZ
MDMerve Erol Deniz
Merve Erol Deniz
ECEray Calıskan
Eray Calıskan
EKEmre Kole
Emre Kole
Background/Objectives: Pelvic organ prolapse (POP) involves anatomical and biomechanical components, yet post-surgical biomechanical changes remain poorly characterized. Vaginal Tactile Imaging (VTI) provides quantitative biomechanical parameters of the vaginal walls and pelvic support structures. This study assessed VTI-derived changes from baseline to 6 months after reconstructive surgery, comparing them with a non-prolapse reference group. Methods: This single-center, prospective cohort study (December 2022–December 2023) enrolled 32 women with POP-Q stage I–IV prolapse scheduled for surgery and 30 women without prolapse. VTI used eight standardized tests generating 46 parameters, with reassessment at 6 months. The primary endpoint was change in the integral pressure parameter P1_I (α = 0.05); secondary endpoints used Bonferroni-adjusted thresholds, with ANCOVA adjusting for age, parity, BMI, and menopausal status. Results: Preoperatively, patients showed markedly lower vaginal wall integrity and stiffness than controls. After adjustment, elasticity differences remained significant, while muscle function differences were largely attenuated. P1_I increased significantly post-operatively (Δ +1.2; 95% CI 0.4–2.0; p = 0.006; d = 0.55). Five secondary endpoints showed nominal improvements (raw p = 0.002–0.033), none surviving correction. Conclusions: Reconstructive surgery significantly improved the primary biomechanical outcome, with modest, unadjusted secondary changes. Findings are hypothesis-generating; confirmation requires powered, matched-control studies with quality-of-life endpoints.